Viking Global Investors LP Biomarin Pharmaceutical Inc Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Viking Global Investors LP holds 10,800,059 shares of BMRN stock, worth $591 Million. This represents 2.55% of its overall portfolio holdings.
Number of Shares
10,800,059
Previous 10,510,550
2.75%
Holding current value
$591 Million
Previous $691 Million
10.51%
% of portfolio
2.55%
Previous 2.34%
Shares
31 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.04 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$972 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$818 Million0.65% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.15MShares$500 Million0.15% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...